Technical data sheets, safety documentation, regulatory reference files, and evaluation samples (50–100g) are available at no charge to qualified R&D laboratories and formulation OEMs. No purchase commitment required.
Manufactured under Japanese Quasi-Drug Raw Material standards with complete lot traceability and certificate of analysis for every batch.
Both Hydroxyapatite-LC and general mineral-derived HAP can start from limestone; Hydroxyapatite-LC is also produced in an eggshell-derived grade (recycled eggshell waste). The difference is everything that happens after — and it determines whether the material performs in a formulation claim or just appears on an ingredient list.
| Criterion | General mineral-derived HAP | Hydroxyapatite-LC |
|---|---|---|
| Raw material origin | Mineral-derived (limestone). Common mineral source. | Two grades: mineral-derived (limestone) and eggshell-derived (recycled eggshell waste). Both Japan, same patented process. |
| Manufacturing process | Standardised processes with potential for variability between producers. Less precise control. | Patented, highly controlled and stable manufacturing process, ensuring uniformity. |
| Particle consistency | Inconsistent particle size and shape, leading to higher lot-to-lot variation. Less predictable performance. | Precisely controlled particle size and morphology for minimal lot-to-lot variation. Consistent performance. |
| Quality standard | General industrial standards, may not be optimised for oral or cosmetic use. Focus on bulk application. | Quality design based on Japanese Quasi-Drug Raw Material standards. Optimised for cosmetic and oral care. |
| Purity and impurity control | Management of impurities like heavy metals can be inconsistent or unclear. Requires further testing. | Rigorous and clearly defined management of impurities, ensuring high purity. Strict criteria. |
| Safety profile (GHS) | Safety data may vary; not always classified with oral care use in mind. Potential for classification ambiguity. | Confirmed as non-hazardous under GHS, ensuring high safety for intended use. Safe and approved. |
| Designed application | Often a general-purpose mineral powder for broad industrial use. Not specialised. | Specifically designed and optimised for cosmetic and oral care applications. Tailored performance. |
| Quality assurance | Quality control standards vary by country and manufacturer. Less rigorous overall oversight. | 100% manufactured and quality controlled under strict standards in Japan. Complete oversight. |
The critical difference lies not in the source rock, but in the precision of the manufacturing process and the purpose of the design. General industrial HAP is engineered for bulk application; Hydroxyapatite-LC is specifically designed and tested for cosmetic and oral care performance claims.
Full physical and chemical specifications, particle size data, solubility, pH in suspension, bulk density, and formulation compatibility parameters.
Available on requestGHS-compliant safety data sheet documenting hazard classification (non-hazardous), handling requirements, first aid, and disposal information.
Available on requestLot-specific CoA confirming purity, particle size distribution, heavy metal limits, and quality parameter compliance for manufacturing batch traceability.
Per lot — on requestSummary of regulatory status across key markets: Japan (Quasi-Drug), EU (SCCS assessment reference), and relevant INCI documentation for formulation dossiers.
Available on requestCurated reference list of peer-reviewed publications covering remineralisation, bacterial adsorption, sensitivity reduction, and whitening efficacy — with relevance notes per application pillar.
Available on requestPhysical powder sample for in-house formulation testing, stability assessment, and sensory evaluation. Shipped to qualified R&D laboratories. No purchase commitment required for evaluation.
Qualified labs — on request